Ikon aset - trading kripto, saham, dan emas di Pluang
Trading di Pluang
Satu platform untuk semua pasar
Download
Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Perbedaan Harga & Kinerja Amman Mineral Internasional Tbk (AMMN) vs UBC Medical Indonesia Tbk. (LABS)

Amman Mineral Internasional Tbk
UBC Medical Indonesia Tbk.

Kinerja harga

Pergerakan harga dalam 24 jam terakhir

Statistik utama

Perbedaan Amman Mineral Internasional Tbk dan UBC Medical Indonesia Tbk.: Amman Mineral Internasional Tbk diperdagangkan di Rp3.350 (kapitalisasi pasar 258,16 T, volume 24 jam 72,41 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp152 (kapitalisasi pasar 556,95 M, volume 24 jam 60,83 jt). Perbedaan utamanya: Amman Mineral Internasional Tbk jauh lebih besar — sekitar 463,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Amman Mineral Internasional Tbk lebih aktif diperdagangkan (72,41 jt vs 60,83 jt). Mana yang lebih baik tergantung tujuan investasimu.

AMMNLABS
Kapitalisasi Pasar
258,16 T556,95 M
Volume
72,41 jt60,83 jt
Lot
724,15 rb608,34 rb
Perputaran
248,17 M10,26 M
Harga Rata-rata
3.427,09168,64
Nilai Transaksi
248,17 M10,26 M
Harga Ekuilibrium Indikatif
3.350152
Volume Ekuilibrium Indikatif
29,86 rb4,52 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

AMMN
Lihat detail
LABS
Lihat detail

Tentang Amman Mineral Internasional Tbk

PT Amman Mineral Internasional Tbk (the Company) was established on September 29, 2015 under the name PT Amman Mineral Internasional and based on Notarial Deed No. 30 of Martina, S.H., notary in Jakarta. The Company was established in connection with the acquisition of AMNT, formerly known as PT Newmont Nusa Tenggara (PTNNT). PTNNT runs its operations under the ownership of a consortium of investors, including Nusa Tenggara Partnership B.V. (NTPBV) which is indirectly owned by Newmont Corporation (Newmont) and Sumitomo Corporation (Sumitomo), PT Multi Daerah Bersaing (PTMDB), PT Indonesia Masbaga Investama (PTIMI), and PT Pukuafu Indah (PTPI). On November 2, 2016, the Company acquired 82.2% shares of PTNNT from NTPBV, PTMDB, and PTIMI, and changed PTNNTs name to AMNT (Acquisition). In December 2020, the Company acquired the remaining outstanding shares of AMNT from PTPI, where the Company is until the date of this Prospectus is issued, owns 99.99% of AMNTs outstanding shares. The remaining 0.01% outstanding shares of AMNT are owned by PT AP Investment (PTAPI), one of the Companys shareholders. Established in 1986, PTNNT began development and construction of the Batu Hijau mine in 1997 and has been producing commodities in the form of copper concentrate which also contains gold and silver as minerals followers since 2000.

Selengkapnya di halaman AMMN

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS